Рет қаралды 1,731
The south Asian region has some of the highest rates of diabetes in the world. Based in India, Wellthy Therapeutics is a leading digital therapeutics company providing comprehensive lifestyle and nutritional support for management of Type 2 diabetes and its co-morbidities.
Their digital therapeutic connects patients with Wellthy’s team of expert health coaches, allowing them to enter data from glucose levels, to food intake and exercise, and get back customised advice and support to manage their disease. This is the only prescribable app for health management in diabetes in India, and is supported by a number of clinical advisors - expert diabetologists who see the effect the system has had on their patients. Studies have already shown that outcomes can be the same or better than traditional approaches to diabetes management.
Apart from close collaborations with top doctors, Wellthy work with everyone from insurance providers, to medical device manufacturers, and pharma to understand better how to integrate the device into the overall health landscape. They’re also about to begin clinical trials for the digital therapy with the support of Research Society for the Study of Diabetes in India, to provide a better research base to demonstrate its efficacy. Wellthy Therapeutics is also ready to expand to the broader Asia Pacific region. With expertise in the specifics of diabetes in Asia, and a team who are able to communicate in a multitude of languages, Wellthy are ready to provide a service to millions of people around the world living with diabetes.